Annual report pursuant to Section 13 and 15(d)

EARNINGS PER SHARE (Tables)

v3.23.1
EARNINGS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

    2022     2021  
    For the Years Ended December 31,  
    2022     2021  
Convertible notes payable     11,726,940       5,489,940  
Warrants to purchase shares of common stock     15,192,493       7,992,558  
Total potentially dilutive shares     26,919,433       13,482,498  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share:

    2022     2021  
    Years Ended December 31,  
    2022     2021  
             
Net loss attributable to the common stockholders   $ (2,929,817 )   $ (3,004,619 )
                 
Basic weighted average outstanding shares of common stock     37,396,591       36,396,594  
Dilutive effect of options and warrants     -       -  
Diluted weighted average common stock and common stock equivalents     37,396,591       36,396,594  
                 
Loss per share:                
Basic and diluted   $ (0.08 )   $ (0.08 )